Unraveling the early events of amyloid-β protein (Aβ) aggregation: techniques for the determination of Aβ aggregate size.

PubWeight™: 0.91‹?›

🔗 View Article (PMC 3317702)

Published in Int J Mol Sci on March 07, 2012

Authors

N Elizabeth Pryor1, Melissa A Moss, Christa N Hestekin

Author Affiliations

1: Ralph E. Martin Department of Chemical Engineering, 3202 Bell Engineering Center, University of Arkansas, Fayetteville, AR 72701, USA; E-Mail: npryor@uark.edu.

Articles citing this

Neuronal amyloid-β accumulation within cholinergic basal forebrain in ageing and Alzheimer's disease. Brain (2015) 1.00

Resolution of oligomeric species during the aggregation of Aβ1-40 using (19)F NMR. Biochemistry (2013) 0.99

Investigation of stable and transient protein-protein interactions: Past, present, and future. Proteomics (2013) 0.88

Experimental traumatic brain injury induces rapid aggregation and oligomerization of amyloid-beta in an Alzheimer's disease mouse model. J Neurotrauma (2013) 0.88

Amyloid β and Tau Alzheimer's disease related pathology is reduced by Toll-like receptor 9 stimulation. Acta Neuropathol Commun (2014) 0.85

Ultrasonic force microscopy for nanomechanical characterization of early and late-stage amyloid-β peptide aggregation. Sci Rep (2014) 0.79

Capillary electrophoresis for the analysis of the effect of sample preparation on early stages of Aβ1-40 aggregation. Electrophoresis (2014) 0.78

Therapeutic potential of mGluR5 targeting in Alzheimer's disease. Front Neurosci (2015) 0.77

Field amplified sample stacking of amyloid beta (1-42) oligomers using capillary electrophoresis. Biomicrofluidics (2016) 0.77

Reduction of amyloid-beta levels in mouse eye tissues by intra-vitreally delivered neprilysin. Exp Eye Res (2015) 0.77

Protective spin-labeled fluorenes maintain amyloid beta peptide in small oligomers and limit transitions in secondary structure. Biochim Biophys Acta (2015) 0.75

Antiaggregation Potential of Padina gymnospora against the Toxic Alzheimer's Beta-Amyloid Peptide 25-35 and Cholinesterase Inhibitory Property of Its Bioactive Compounds. PLoS One (2015) 0.75

Confocal Spectroscopy to Study Dimerization, Oligomerization and Aggregation of Proteins: A Practical Guide. Int J Mol Sci (2016) 0.75

Articles cited by this

(truncated to the top 100)

Common structure of soluble amyloid oligomers implies common mechanism of pathogenesis. Science (2003) 18.18

A specific amyloid-beta protein assembly in the brain impairs memory. Nature (2006) 16.19

Amyloid plaque core protein in Alzheimer disease and Down syndrome. Proc Natl Acad Sci U S A (1985) 16.10

Diffusible, nonfibrillar ligands derived from Abeta1-42 are potent central nervous system neurotoxins. Proc Natl Acad Sci U S A (1998) 16.04

A beta oligomers - a decade of discovery. J Neurochem (2007) 8.88

Protofibrils, pores, fibrils, and neurodegeneration: separating the responsible protein aggregates from the innocent bystanders. Annu Rev Neurosci (2003) 8.44

Sorting single molecules: application to diagnostics and evolutionary biotechnology. Proc Natl Acad Sci U S A (1994) 7.46

Soluble amyloid beta peptide concentration as a predictor of synaptic change in Alzheimer's disease. Am J Pathol (1999) 7.16

National Institute on Aging-Alzheimer's Association guidelines for the neuropathologic assessment of Alzheimer's disease: a practical approach. Acta Neuropathol (2011) 6.00

Oligomeric and fibrillar species of amyloid-beta peptides differentially affect neuronal viability. J Biol Chem (2002) 5.63

Folding proteins in fatal ways. Nature (2003) 5.58

Amyloid beta -protein (Abeta) assembly: Abeta 40 and Abeta 42 oligomerize through distinct pathways. Proc Natl Acad Sci U S A (2002) 5.46

Amyloid beta-protein fibrillogenesis. Detection of a protofibrillar intermediate. J Biol Chem (1997) 5.07

On the nucleation and growth of amyloid beta-protein fibrils: detection of nuclei and quantitation of rate constants. Proc Natl Acad Sci U S A (1996) 4.75

Amyloid beta-protein fibrillogenesis. Structure and biological activity of protofibrillar intermediates. J Biol Chem (1999) 4.64

The relationship between Abeta and memory in the Tg2576 mouse model of Alzheimer's disease. J Neurosci (2002) 4.27

In vitro characterization of conditions for amyloid-beta peptide oligomerization and fibrillogenesis. J Biol Chem (2002) 4.20

Fibril specific, conformation dependent antibodies recognize a generic epitope common to amyloid fibrils and fibrillar oligomers that is absent in prefibrillar oligomers. Mol Neurodegener (2007) 4.15

Protofibrillar intermediates of amyloid beta-protein induce acute electrophysiological changes and progressive neurotoxicity in cortical neurons. J Neurosci (1999) 3.92

Structural conversion of neurotoxic amyloid-beta(1-42) oligomers to fibrils. Nat Struct Mol Biol (2010) 3.75

Effects of secreted oligomers of amyloid beta-protein on hippocampal synaptic plasticity: a potent role for trimers. J Physiol (2006) 3.74

Amyloid-β protein oligomerization and the importance of tetramers and dodecamers in the aetiology of Alzheimer's disease. Nat Chem (2009) 3.66

Small molecule inhibitors of aggregation indicate that amyloid beta oligomerization and fibrillization pathways are independent and distinct. J Biol Chem (2007) 3.42

Kinetic theory of fibrillogenesis of amyloid beta-protein. Proc Natl Acad Sci U S A (1997) 3.40

The oligomerization of amyloid beta-protein begins intracellularly in cells derived from human brain. Biochemistry (2000) 3.31

Amyloid beta protein (A beta) in Alzheimer's disease brain. Biochemical and immunocytochemical analysis with antibodies specific for forms ending at A beta 40 or A beta 42(43). J Biol Chem (1995) 3.17

Globular amyloid beta-peptide oligomer - a homogenous and stable neuropathological protein in Alzheimer's disease. J Neurochem (2005) 3.06

Hippocampal synaptic loss in early Alzheimer's disease and mild cognitive impairment. Neurobiol Aging (2005) 2.97

Ion mobility-mass spectrometry. J Mass Spectrom (2008) 2.91

Amyloid beta-protein assembly and Alzheimer disease. J Biol Chem (2008) 2.90

Emerging ideas on the molecular basis of protein and peptide aggregation. Curr Opin Struct Biol (2003) 2.85

Polymorphism in the intermediates and products of amyloid assembly. Curr Opin Struct Biol (2007) 2.75

Amyloid-beta oligomers: their production, toxicity and therapeutic inhibition. Biochem Soc Trans (2002) 2.55

Common mechanisms of amyloid oligomer pathogenesis in degenerative disease. Neurobiol Aging (2006) 2.50

Monoclonal antibodies that target pathological assemblies of Abeta. J Neurochem (2006) 2.32

Protein aggregation kinetics, mechanism, and curve-fitting: a review of the literature. Biochim Biophys Acta (2008) 2.29

Amyloid beta-protein: monomer structure and early aggregation states of Abeta42 and its Pro19 alloform. J Am Chem Soc (2005) 2.19

Chemistry for the analysis of protein-protein interactions: rapid and efficient cross-linking triggered by long wavelength light. Proc Natl Acad Sci U S A (1999) 2.19

Analysis of double-stranded DNA by capillary electrophoresis with laser-induced fluorescence detection using the monomeric dye SYBR green I. Anal Biochem (1995) 2.03

Neurotoxic protein oligomers--what you see is not always what you get. Amyloid (2005) 1.84

Rapid photochemical cross-linking--a new tool for studies of metastable, amyloidogenic protein assemblies. Acc Chem Res (2004) 1.75

Coupling high-pressure MALDI with ion mobility/orthogonal time-of-flight mass spectrometry. Anal Chem (2000) 1.69

Oligomerization of endogenous and synthetic amyloid beta-protein at nanomolar levels in cell culture and stabilization of monomer by Congo red. Biochemistry (1998) 1.54

Fibrillar oligomers nucleate the oligomerization of monomeric amyloid beta but do not seed fibril formation. J Biol Chem (2009) 1.53

Structural and kinetic features of amyloid beta-protein fibrillogenesis. Amyloid (1998) 1.50

Sensitive ELISA detection of amyloid-beta protofibrils in biological samples. J Neurochem (2007) 1.46

Amyloid-beta oligomers are inefficiently measured by enzyme-linked immunosorbent assay. Ann Neurol (2005) 1.45

Structural studies of soluble oligomers of the Alzheimer beta-amyloid peptide. J Mol Biol (2000) 1.45

Microfabricated devices in biotechnology and biochemical processing. Trends Biotechnol (2002) 1.43

Peptide aggregation in neurodegenerative disease. Annu Rev Biomed Eng (2002) 1.40

NMR studies of amyloid beta-peptides: proton assignments, secondary structure, and mechanism of an alpha-helix----beta-sheet conversion for a homologous, 28-residue, N-terminal fragment. Biochemistry (1992) 1.37

Growth of beta-amyloid(1-40) protofibrils by monomer elongation and lateral association. Characterization of distinct products by light scattering and atomic force microscopy. Biochemistry (2002) 1.35

ESI/ion trap/ion mobility/time-of-flight mass spectrometry for rapid and sensitive analysis of biomolecular mixtures. Anal Chem (1999) 1.34

Amyloid beta protein: Abeta40 inhibits Abeta42 oligomerization. J Am Chem Soc (2009) 1.30

Mechanisms of amyloid fibril self-assembly and inhibition. Model short peptides as a key research tool. FEBS J (2005) 1.30

Neocortical and hippocampal amyloid-β and tau measures associate with dementia in the oldest-old. Brain (2011) 1.29

Amyloid beta-peptide polymerization studied using fluorescence correlation spectroscopy. Chem Biol (1999) 1.26

Silicon cluster ions: Evidence for a structural transition. Phys Rev Lett (1991) 1.26

Structure and function of amyloid in Alzheimer's disease. Prog Neurobiol (2004) 1.25

Fractionation and characterization of oligomeric, protofibrillar and fibrillar forms of beta-amyloid peptide. Biochem J (2000) 1.23

Quantitative analysis of amyloid beta peptides in cerebrospinal fluid of Alzheimer's disease patients by immunoaffinity purification and stable isotope dilution liquid chromatography/negative electrospray ionization tandem mass spectrometry. Rapid Commun Mass Spectrom (2006) 1.22

Review: amyloidogenesis-unquestioned answers and unanswered questions. J Struct Biol (2000) 1.22

Monitoring copopulated conformational states during protein folding events using electrospray ionization-ion mobility spectrometry-mass spectrometry. J Am Soc Mass Spectrom (2007) 1.22

Temperature-dependent beta-sheet formation in beta-amyloid Abeta(1-40) peptide in water: uncoupling beta-structure folding from aggregation. Biochim Biophys Acta (2000) 1.22

The role of amyloid-beta derived diffusible ligands (ADDLs) in Alzheimer's disease. Curr Top Med Chem (2006) 1.21

A study of peptide-peptide interactions using MALDI ion mobility o-TOF and ESI mass spectrometry. J Am Soc Mass Spectrom (2002) 1.18

Size-dependent neurotoxicity of beta-amyloid oligomers. Arch Biochem Biophys (2010) 1.17

Probing the kinetics of beta-amyloid self-association. J Struct Biol (2000) 1.15

Miniaturized total analysis systems for biological analysis. Fresenius J Anal Chem (2001) 1.12

Amino acid position-specific contributions to amyloid beta-protein oligomerization. J Biol Chem (2009) 1.10

Protofibril formation of amyloid beta-protein at low pH via a non-cooperative elongation mechanism. J Biol Chem (2005) 1.07

In vitro studies of amyloid beta-protein fibril assembly and toxicity provide clues to the aetiology of Flemish variant (Ala692-->Gly) Alzheimer's disease. Biochem J (2001) 1.06

Spontaneous in vitro formation of supramolecular beta-amyloid structures, "betaamy balls", by beta-amyloid 1-40 peptide. Biochemistry (2001) 1.06

Unique physicochemical profile of beta-amyloid peptide variant Abeta1-40E22G protofibrils: conceivable neuropathogen in arctic mutant carriers. J Mol Biol (2004) 1.06

Sedimentation velocity analysis of amyloid oligomers and fibrils. Methods Enzymol (2006) 1.03

Antimicrobial properties of amyloid peptides. Mol Pharm (2011) 1.02

Sensitive detection of Aβ protofibrils by proximity ligation--relevance for Alzheimer's disease. BMC Neurosci (2010) 1.02

Two distinct amyloid beta-protein (Abeta) assembly pathways leading to oligomers and fibrils identified by combined fluorescence correlation spectroscopy, morphology, and toxicity analyses. J Biol Chem (2011) 1.00

Biophysical analyses of synthetic amyloid-beta(1-42) aggregates before and after covalent cross-linking. Implications for deducing the structure of endogenous amyloid-beta oligomers. Biochemistry (2009) 0.99

Evidence of the existence of micelles in the fibrillogenesis of beta-amyloid peptide. J Phys Chem B (2005) 0.99

Soluble aggregates of the amyloid-beta protein selectively stimulate permeability in human brain microvascular endothelial monolayers. J Neurochem (2008) 0.97

Field-flow fractionation in bioanalysis: A review of recent trends. Anal Chim Acta (2009) 0.96

Amyloid fibril proteins. Mech Ageing Dev (2002) 0.96

Beta-amyloid protein oligomers induced by metal ions and acid pH are distinct from those generated by slow spontaneous ageing at neutral pH. Eur J Biochem (2003) 0.96

Detection of a chemical warfare agent simulant in various aerosol matrixes by ion mobility time-of-flight mass spectrometry. Anal Chem (2005) 0.96

An improved method for generating consistent soluble amyloid-beta oligomer preparations for in vitro neurotoxicity studies. J Neurosci Methods (2010) 0.95

Selective destabilization of soluble amyloid beta oligomers by divalent metal ions. Biochem Biophys Res Commun (2006) 0.95

A safe, blood-brain barrier permeable triphenylmethane dye inhibits amyloid-β neurotoxicity by generating nontoxic aggregates. ACS Chem Neurosci (2011) 0.95

Isomers of Small Carbon Cluster Anions: Linear Chains with up to 20 Atoms. Science (1993) 0.95

Alzheimer's disease: epidemiology, genetics, and beyond. Neurosci Bull (2008) 0.92

Cell-derived soluble oligomers of human amyloid-beta peptides disturb cellular homeostasis and induce apoptosis in primary hippocampal neurons. J Neural Transm (Vienna) (2009) 0.91

Capillary electrophoresis studies on the aggregation process of beta-amyloid 1-42 and 1-40 peptides. Electrophoresis (2004) 0.91

Oxidation of methionine 35 attenuates formation of amyloid beta -peptide 1-40 oligomers. J Biol Chem (2002) 0.91

Quasihomogeneous nucleation of amyloid beta yields numerical bounds for the critical radius, the surface tension, and the free energy barrier for nucleus formation. J Chem Phys (2008) 0.90

Oligomerizaiton and fibril asssembly of the amyloid-beta protein. Biochim Biophys Acta (2000) 0.90

Mass spectrometry and the amyloid problem--how far can we go in the gas phase? J Am Soc Mass Spectrom (2010) 0.90

Atmospheric pressure matrix-assisted laser desorption/ionization with analysis by ion mobility time-of-flight mass spectrometry. Rapid Commun Mass Spectrom (2004) 0.90

A strategy for designing a peptide probe for detection of β-amyloid oligomers. Chembiochem (2010) 0.89

Single particle detection of Abeta aggregates associated with Alzheimer's disease. Biochem Biophys Res Commun (2007) 0.88

The monomer state of beta-amyloid: where the Alzheimer's disease protein meets physiology. Rev Neurosci (2010) 0.87

Articles by these authors

Growth of beta-amyloid(1-40) protofibrils by monomer elongation and lateral association. Characterization of distinct products by light scattering and atomic force microscopy. Biochemistry (2002) 1.35

Amyloid-beta protofibrils differ from amyloid-beta aggregates induced in dilute hexafluoroisopropanol in stability and morphology. J Biol Chem (2004) 1.03

Soluble aggregates of the amyloid-beta protein selectively stimulate permeability in human brain microvascular endothelial monolayers. J Neurochem (2008) 0.97

Activation of brain endothelium by soluble aggregates of the amyloid-β protein involves nuclear factor-κB. Curr Alzheimer Res (2011) 0.95

Soluble aggregates of the amyloid-beta peptide are trapped by serum albumin to enhance amyloid-beta activation of endothelial cells. J Biol Eng (2009) 0.91

Soluble aggregates of the amyloid-beta protein activate endothelial monolayers for adhesion and subsequent transmigration of monocyte cells. J Neurochem (2007) 0.90

High-throughput, high-sensitivity genetic mutation detection by tandem single-strand conformation polymorphism/heteroduplex analysis capillary array electrophoresis. Anal Chem (2002) 0.89

Multiplexed p53 mutation detection by free-solution conjugate microchannel electrophoresis with polyamide drag-tags. Anal Chem (2007) 0.88

Quartz crystal microbalance analysis of growth kinetics for aggregation intermediates of the amyloid-beta protein. Anal Biochem (2008) 0.87

Rapid assembly of amyloid-beta peptide at a liquid/liquid interface produces unstable beta-sheet fibers. Biochemistry (2005) 0.86

Synthesis and characterization of thermally responsive Pluronic F127-chitosan nanocapsules for controlled release and intracellular delivery of small molecules. ACS Nano (2010) 0.86

Amyloid-beta aggregates formed at polar-nonpolar interfaces differ from amyloid-beta protofibrils produced in aqueous buffers. Microsc Res Tech (2005) 0.83

Optimized sample preparation for tandem capillary electrophoresis single-stranded conformational polymorphism/ heteroduplex analysis. Biotechniques (2002) 0.83

Inhibition of amyloid-β aggregation by coumarin analogs can be manipulated by functionalization of the aromatic center. Bioorg Med Chem (2011) 0.81

Technical challenges in applying capillary electrophoresis-single strand conformation polymorphism for routine genetic analysis. Electrophoresis (2002) 0.79

Comparative study of inhibition at multiple stages of amyloid-beta self-assembly provides mechanistic insight. Mol Pharmacol (2009) 0.78

Rationally designed peptoids modulate aggregation of amyloid-beta 40. ACS Chem Neurosci (2014) 0.78

Capillary electrophoresis for the analysis of the effect of sample preparation on early stages of Aβ1-40 aggregation. Electrophoresis (2014) 0.78

Capillary electrophoresis-single strand conformation polymorphism for the detection of multiple mutations leading to tuberculosis drug resistance. J Microbiol Methods (2012) 0.78

Conformational Dynamics of Specific Aβ Oligomers Govern Their Ability To Replicate and Induce Neuronal Apoptosis. Biochemistry (2016) 0.78

Monitoring insulin aggregation via capillary electrophoresis. Int J Mol Sci (2011) 0.77